Chimeric antigen receptor T-cell therapy, or CAR T-cell therapy, is an innovative and promising treatment approach that has revolutionized the field of cancer therapy.
Pancreatic cancer is a tough disease to beat, with only 11.5% of patients surviving more than five years. But Nebraska Medicine researchers are working hard to find new ways to boost survival.
When Scott and Teresa Hueber celebrated their 40th wedding anniversary this past summer, it was much more than a celebration of marriage. It was also a celebration of life.
Maximizing your nutrition during and after cancer treatment is one of the important goals addressed by the Nebraska Medicine Cancer Survivorship Program.
Support is provided by trained peer breast cancer survivors, who are community members with similar culture, race or ethnicity as the patients they support. Their goal is to help patients find access to health care resources.
Catching disease in the earliest stages leads to more effective treatments, improved outcomes and better quality of life. Just as a mammogram, blood pressure check, or colonoscopy screening can be lifesaving, the same holds for annual lung cancer screenings for those who meet the criteria.
Philanthropy has always been an integral part of Colby Zeuli’s life. So when Colby began planning her wedding, she didn’t think twice when she requested that guests donate to the University of Nebraska Medical Center Hematological Malignancies Fund. Colby’s mother, Stacie Greene, is still here today due to the care she received at Nebraska Medical Center 29 years ago when she was diagnosed with non-Hodgkin’s lymphoma.
When Kim Bate went to an appointment with his family physician in October 2018, he didn't consider the worst-case scenario. Bate had a rash, but nothing too extreme. Still, when Kim's doctor informed him that he believed Kim had an undiagnosed cancer and they'd need to run more tests, it wasn't a complete surprise.
